ITTO20040682A1 - Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare - Google Patents

Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Info

Publication number
ITTO20040682A1
ITTO20040682A1 IT000682A ITTO20040682A ITTO20040682A1 IT TO20040682 A1 ITTO20040682 A1 IT TO20040682A1 IT 000682 A IT000682 A IT 000682A IT TO20040682 A ITTO20040682 A IT TO20040682A IT TO20040682 A1 ITTO20040682 A1 IT TO20040682A1
Authority
IT
Italy
Prior art keywords
effect
oral administration
salutistic
formulation
health
Prior art date
Application number
IT000682A
Other languages
English (en)
Inventor
Angelo Luigi Rovati
Paolo Senin
Ivo Setnikar
Original Assignee
Rottapharm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm S R L filed Critical Rottapharm S R L
Priority to IT000682A priority Critical patent/ITTO20040682A1/it
Publication of ITTO20040682A1 publication Critical patent/ITTO20040682A1/it
Priority to DK05792107T priority patent/DK1827136T3/da
Priority to DE602005007380T priority patent/DE602005007380D1/de
Priority to EP05792107A priority patent/EP1827136B1/en
Priority to PT05792107T priority patent/PT1827136E/pt
Priority to US11/576,644 priority patent/US20080102082A1/en
Priority to PCT/EP2005/054691 priority patent/WO2006037725A1/en
Priority to ES05792107T priority patent/ES2308550T3/es
Priority to AT05792107T priority patent/ATE397389T1/de
Priority to SI200530379T priority patent/SI1827136T1/sl
Priority to PL05792107T priority patent/PL1827136T3/pl
Priority to TW094134749A priority patent/TWI359667B/zh
Priority to CY20081100945T priority patent/CY1108314T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/60—Edible seaweed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000682A 2004-10-07 2004-10-07 Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare ITTO20040682A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT000682A ITTO20040682A1 (it) 2004-10-07 2004-10-07 Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare
PL05792107T PL1827136T3 (pl) 2004-10-07 2005-09-20 Preparat do podawania doustnego korzystnie wpływający na układ sercowo-naczyniowy
PT05792107T PT1827136E (pt) 2004-10-07 2005-09-20 Formulação para administração oral que tem um efeito benéfico no sistema cardiovascular
DE602005007380T DE602005007380D1 (de) 2004-10-07 2005-09-20 Formulierung für die orale verabreichung mit gesundheitsfördernder wirkung auf das herz-kreislauf-system
EP05792107A EP1827136B1 (en) 2004-10-07 2005-09-20 Formulation for oral administration having a health-promoting effect on the cardiovascular system
DK05792107T DK1827136T3 (da) 2004-10-07 2005-09-20 Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet
US11/576,644 US20080102082A1 (en) 2004-10-07 2005-09-20 Formulation for Oral Administration Having a Health-Promoting Effect on the Cardiovascular System
PCT/EP2005/054691 WO2006037725A1 (en) 2004-10-07 2005-09-20 Formulation for oral administration having a health-promoting effect on the cardiovascular system
ES05792107T ES2308550T3 (es) 2004-10-07 2005-09-20 Formulacion para administracion oral que ejerce un efecto reconstituyente sobre el sistema cardiovascular.
AT05792107T ATE397389T1 (de) 2004-10-07 2005-09-20 Formulierung für die orale verabreichung mit gesundheitsfördernder wirkung auf das herz- kreislauf-system
SI200530379T SI1827136T1 (sl) 2004-10-07 2005-09-20 Formulacija za oralno dajanje, ki ima za zdravje koristen učinek na kardiovaskularni sistem
TW094134749A TWI359667B (en) 2004-10-07 2005-10-05 Formulation for oral administration having a healt
CY20081100945T CY1108314T1 (el) 2004-10-07 2008-09-03 Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000682A ITTO20040682A1 (it) 2004-10-07 2004-10-07 Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Publications (1)

Publication Number Publication Date
ITTO20040682A1 true ITTO20040682A1 (it) 2005-01-07

Family

ID=35395774

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000682A ITTO20040682A1 (it) 2004-10-07 2004-10-07 Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Country Status (13)

Country Link
US (1) US20080102082A1 (it)
EP (1) EP1827136B1 (it)
AT (1) ATE397389T1 (it)
CY (1) CY1108314T1 (it)
DE (1) DE602005007380D1 (it)
DK (1) DK1827136T3 (it)
ES (1) ES2308550T3 (it)
IT (1) ITTO20040682A1 (it)
PL (1) PL1827136T3 (it)
PT (1) PT1827136E (it)
SI (1) SI1827136T1 (it)
TW (1) TWI359667B (it)
WO (1) WO2006037725A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI323312B (en) * 2005-06-23 2010-04-11 Honda Motor Co Ltd Gas-liquid separation device of engine
ITTO20060239A1 (it) 2006-03-30 2007-09-30 Rotthapharm S P A Formulazione per somministrazione orale con effetti salutistici sull'apparato cardiovascolare
US20120171285A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
US20100119600A1 (en) * 2007-06-01 2010-05-13 Joar Opheim Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
FR2950061B1 (fr) 2009-09-11 2013-12-20 Coatex Sas Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations
ITMI20121696A1 (it) * 2012-10-09 2014-04-10 Ddf Group S A S Composizioni per il trattamento delle iperlipidemie
ITUB20150541A1 (it) 2015-03-03 2016-09-03 Acraf Composizione comprendente sostanze e/o estratti naturali
CN105878801A (zh) * 2016-05-10 2016-08-24 胡铭 一种具有降血脂作用的红曲虾青素组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952393A (en) * 1998-02-12 1999-09-14 Sorkin, Jr.; Harlan Lee Composition for reducing serum cholesterol levels
US20030104090A1 (en) * 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
US6436406B1 (en) * 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors

Also Published As

Publication number Publication date
PL1827136T3 (pl) 2008-11-28
WO2006037725A1 (en) 2006-04-13
TWI359667B (en) 2012-03-11
DE602005007380D1 (de) 2008-07-17
PT1827136E (pt) 2008-09-09
US20080102082A1 (en) 2008-05-01
DK1827136T3 (da) 2008-09-15
ES2308550T3 (es) 2008-12-01
EP1827136A1 (en) 2007-09-05
CY1108314T1 (el) 2014-02-12
ATE397389T1 (de) 2008-06-15
TW200621272A (en) 2006-07-01
SI1827136T1 (sl) 2008-12-31
EP1827136B1 (en) 2008-06-04

Similar Documents

Publication Publication Date Title
ITTO20060239A1 (it) Formulazione per somministrazione orale con effetti salutistici sull'apparato cardiovascolare
TW200621272A (en) Formulation for oral administration having a health-promoting effect on the cardiovascular system
WO2007092755A3 (en) Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
MY143795A (en) Tetrahydropyridoindole derivatives
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2007043057A3 (en) Compositions for nasal delivery
MX2007008021A (es) Composiciones que incluyen hierro.
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2007123995A3 (en) Camptothecin-analog with a novel, “flipped” lactone-stable, e-ring and methods for making and using same
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
WO2006032115A3 (en) Composition against cardiovascular diseases
WO2004069203A3 (en) Oral compositions of fenretinide having increased bioavailability and methods of using the same
CA2578881A1 (en) Vitamin d compositions and method of administration to a human being
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
WO2014082027A3 (en) Antioxidant dietary supplement
WO2008108285A1 (ja) ペプチド
SI1684719T1 (sl) Sestavki alfa antitripsina in postopki zdravljenja ob uporabi takih sestavkov
WO2012058276A3 (en) Methods and materials for reducing mutiple risk factors associated with the metabolic syndrom
WO2012143857A8 (en) Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
WO2016014680A8 (en) Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men
WO2007003447A3 (en) Coated granular formulations
JP2015134867A (ja) 抗酸化剤
AU2566400A (en) Pharmaceutical combination of progesterone and folic acid